Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic

Introduction: OnabotulinumtoxinA (BT-A) is a preventive treatment for chronic migraine (CM), which needs to be administered regularly by a trained clinician every 3 months. The spread of the severe acute respiratory syndrome coronavirus-2 pandemic has forced many patients to momentarily stop the sch...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Carlo Baraldi, Raffaele Ornello, Valentina Favoni, Simona Sacco, Valeria Caponnetto, Giulia Pierangeli, Luca Pani, Sabina Cevoli, Simona Guerzoni
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-04-01
coleção:	Frontiers in Neurology
Assuntos:	chronic migraine severe acute respiratory syndrome coronavirus-2 pandemic medication overuse headache onabotulinumtoxinA migraine frequency
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fneur.2021.647995/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!